![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug to fight leukemia in sight, say Australian researchers
After discovering a potential molecular "target" for leukemia, Australian researchers say a drug to fight...
Zonegran (Zonisamide) for the Treatment of Epilepsy, Switzerland
Zonegran (Zonisamide) is an anti-epileptic drug indicated for the treatment of partial seizures in adults...
Pharma 2020
A recent study by PricewaterhouseCoopers (PwC) examined the future of pharma and revealed essential technological...
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes, India
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of...
Trophos will present results of pivotal phase II/III study of olesoxime in spinal muscular...
Trophos and AFM-Telethon (The French Muscular Dystrophy Association) today announce that data from the pivotal...
Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone(R) Lispro
Adocia (Euronext Paris: FR0011184241 - ADOC) announces positive results from a phase IIa clinical trial...
Body kills ‘spontaneous’ blood cancers on a daily basis
Immune cells undergo 'spontaneous' changes on a daily basis that could lead to cancers if...
IMI Builds Collaborations to Monitor Vaccine Safety and Drug Effectiveness
The Innovative Medicines Initiative (IMI) is calling experts to join forces and tackle two challenges...